View Cart  

Canadian Drugmakers Expect Higher Costs From EU Proposals

A A
A report conducted by Canada’s generics industry shows changes to the country’s drug patent system would add almost $3 billion annually to its drug costs.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00